Concepedia

Daniel Knighton

DK

Statistics

Publications

3

Citations

425

H-Index

3

Active since

1989

Affiliations

Pfizer (United States)(Current)

Daniel Knighton is an author at Pfizer (United States) specializing in tumor biology, medicinal chemistry, and drug discovery.

Top concepts

Publications per year

1989–2012

3

Publications

3

Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth

Brion W. Murray, Chuangxing Guo, Joseph Piraino et al. · Proceedings of the National Academy of Sciences · 2010 · 318 citations · Full text

Discovery of Pyrroloaminopyrazoles as Novel PAK Inhibitors

Chuangxing Guo, Indrawan McAlpine, Junhu Zhang et al. · Journal of Medicinal Chemistry · 2012 · 59 citations · Full text

, , +15

Effects of Whey Proteins on the Proteolysis of Cheddar Cheese Slurries (A Model for the Maturation of Cheeses Made from Ultrafiltered Milk)

J. Wade Harper, Mani Iyer, Daniel Knighton et al. · Journal of Dairy Science · 1989 · 48 citations · Full text

1–3 of 3